Caricamento...
Mineralocorticoid Receptor Antagonists for Treatment of Hypertension and Heart Failure
Spironolactone and eplerenone are both mineralocorticoid-receptor antagonists. These compounds block both the epithelial and nonepithelial actions of aldosterone, with the latter assuming increasing clinical relevance. Spironolactone and eplerenone both affect reductions in blood pressure either as...
Salvato in:
| Pubblicato in: | Methodist Debakey Cardiovasc J |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
The Methodist Hospital Houston, Texas
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4814010/ https://ncbi.nlm.nih.gov/pubmed/27057293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14797/mdcj-11-4-235 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|